Key Word(s): 1. HCV; 2. hepatitis; 3. chemokine; 4. IP-10; Presenting Author: GANG SHI Additional Authors: WEI LU Corresponding Author: GANG SHI Affiliations: Tianjin Second People’s Hospital Objective: To implement two-way connection of found scientific research and clinical application about the traditional Chinese medicine prevention and cure viral hepatitis by translational medicine mode. Methods: At the moment of undertaking “The 11th Five Years Key Programs for Science and Technology Development of China”, to organize research team of translational
medicine, manage projects distribution and application find more of the traditional Chinese medicine prevention and cure viral hepatitis as a whole and share scientific research equipment, biological specimen, bio-information DZNeP base. Put research outcomes into practice by scientific operation
mechanism. Results: Our hospital has 4 national level items understudied and 4 bureau level items after implement translational medicine mode in recent 2 years. We has cultivated 3 doctors on combination of traditional Chinese medicine with Western medicine, designated 4 people to receive Master of medicine and Doctor Education, 3 people has got master academic degree. Conclusion: Translational medicine mode of the traditional Chinese medicine prevention and cure viral hepatitis can break traditional medicine research separation, re-establish research system of the traditional Chinese medicine prevention and cure viral hepatitis and carry out two-way Translation from bench to bedside. Key Word(s): 1. translational medi; 2. viral hepatitis; 3. Chinese medicine; Presenting Author: CHUNYAN WANG Corresponding Author: CHUNYAN WANG Affiliations: Tianjin selleckchem Second People’s Hospital Objective: To investigate the diagnostic value of CAP by transient elastography technique for liver steatosis in patients with chronic hepatitis B
(CHB). Methods: Eighty-eight patients with CHB were enrolled in this study. All of the patients underwent CAP by transient elastography technique, and they underwent liver biopsy at the same term. With liver biopsy as the gold standard, ROC curves were delineated for different endpoints. The area under the ROC curves (AUC) was used to evaluate the diagnostic value for liver steatosis in patients with CHB. Results: There was a positive correlation between the AUCs of CAP and liver pathological stage (r = 0.582, p < 0.05). The CAP between S0, S1, S2, S3 were significantly different (F = 17.79, P < 0.01). The AUC values of CAP were 0.711 (0.592–0.870), 0.868 (0.748–0.989), 0.974 (0.922–1.026) for S > 0, S > 1, S > 2, respectively. The optimal cut-off values were 219.5, 230.0, 283.5 dB/m. Conclusion: CAP is a novel tool to assess the degree of steatosis. Key Word(s): 1. LSM; 2. CAP; 3. hepatitis B; 4.
No related posts.